Alert: Major Price Advance (1/13/25)-Sage Therapeutics Inc (NASDAQ: SAGE).

out_logo_500#71841.jpg

On 1/13/25, Sage Therapeutics Inc (NASDAQ: SAGE) stock enjoyed a major increase of 35.1%, closing at $7.50. Moreover, trading volume in this advance was exceptionally high at 881% of normal. The stock has been extremely weak relative to the market over the last nine months but has risen 29.8% during the last week.

out_mm#71841.jpg

Current PriceTarget Research Rating

Sage Therapeutics has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Sage Therapeutics has a slightly positive Appreciation Score of 66 but a poor Power Rating of 16, producing the Negative Value Trend Rating.

Rating Review

In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.


*